November 28, 2023
Webinar
Strafford Publications
As part of the Strafford Publications’ virtual programming, Finnegan attorney Yieyie Yang will discuss recently released FDA draft guidance helping to clarify the application process for approval of biosimilar and interchangeable biosimilar products. The panel will also explain how guidance differs from the past and ways it impacts the current application process and developmental strategies. For more information, or to register, please see Strafford’s website.
INCONTESTABLE® Blog
April 19, 2024
Prosecution First Blog
March 29, 2024
Conference
2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities
March 20, 2024
Boston
Ad Law Buzz Blog
“Banning” a Banned Ingredients Claim: NAD’s Application (and Expansion) of the FTC’s Green Guides
March 18, 2024
INCONTESTABLE® Blog
Trademark Application for Fruity Pebbles’ Colors—“Yabba-Dabba-Delicious” but Not Protectable
March 8, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.